Toronto, Ontario–(Newsfile Corp. – January 28, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia” or the “Company”) is pleased to provide the following corporate update to its shareholders...
Read more
Britannia sells its UK lab and testing business to a private UK-based acquiror for total enterprise value of up to £24.2 million (CAD$43.6 million) Initial consideration of £18.7 million (CAD$33.7 million) payable in cash on closing Additional...
Read more
Get in touch with our team of professionals and let’s start a conversation.